Retina Society 2018: AMD Session Part II
Yoshihiro Yonekawa, MD Mass Eye & Ear / Boston Children’s RETINA Roundup Co-Editor We continue coverage of the 2018 Retina Society annual meeting in San Francisco. Yesterday we presented summaries…
Category: AMD
Retina Society 2018: AMD Part I (Including First-Time Presentation of Genentech’s Bispecific Anti-VEGF/Ang2 Agent for Neovascular AMD)
Yoshihiro Yonekawa, MD Mass Eye & Ear / Boston Children’s RETINA Roundup Co-Editor The age-related macular degeneration (AMD) session at Retina Society is always jam-packed. Patients with AMD comprise a…
Not All is Dry with Dry AMD
And now…finally…some good news in dry AMD! Geographic atrophy (GA) remains a significant unmet need that has been met with great attention by investigators and industry. However, until now, all…